•
Dec 31, 2024

IGM Biosciences Q4 2024 Earnings Report

Expected Revenue:$270K
-61.4% YoY
Expected EPS:-$0.79
+25.5% YoY
Total Revenue
$412K
Previous year: $651K
-36.7%
Gross Profit
-$1.94M
Previous year: -$1.53M
+26.9%
Cash and Equivalents
$184M
Previous year: $338M
-45.6%
Free Cash Flow
-$35.7M
Previous year: -$49.5M
-27.9%
Total Assets
$266M
Previous year: $423M
-37.2%

IGM Biosciences

IGM Biosciences